France carries on with new regulation despite the Commission
This article was originally published in Clinica
France is due to publish its new law introducing more stringent requirements for high-risk medical devices despite opposition from the European Commission which will prevent it from enforcing the requirements before August 5.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.